Literature DB >> 23535464

Cushing's syndrome.

Julia Kate Prague1, Stephanie May, Benjamin Cameron Whitelaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23535464     DOI： 10.1136/bmj.f945

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Phosphodiesterases and adrenal Cushing in mice and humans.

Authors:  E Szarek; C A Stratakis
Journal:  Horm Metab Res       Date:  2014-09-18       Impact factor: 2.936

2.  Long-term follow-up for ectopic ACTH-secreting pituitary adenoma in a single tertiary medical center and a literature review.

Authors:  Jianyu Zhu; Lin Lu; Yong Yao; Shi Chen; Wei Li; Hui You; Feng Feng; Ming Feng; Yi Zhang; Zhicheng Wang; Xu Sun; Xiaoxu Li; Huijuan Zhu; Renzhi Wang; Zhaolin Lu
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

3.  Metachronous bilateral adrenocortical functional adenomas causing adrenocorticotropic hormone-independent Cushing's syndrome.

Authors:  Kang Cheng; Wanli Cao; Jun Dai; Xin Huang; Baoxing Huang; Henchuan Su; Fukang Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

4.  Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects.

Authors:  Clemens Honeder; Elisabeth Engleder; Hanna Schöpper; Markus Krause; Lukas David Landegger; Roberto Plasenzotti; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  Laryngoscope       Date:  2014-11-10       Impact factor: 3.325

Review 5.  A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.

Authors:  Cara Tomas; Julia Newton; Stuart Watson
Journal:  ISRN Neurosci       Date:  2013-09-30

6.  Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.

Authors:  Lukas D Landegger; Clemens Honeder; Chengjing Zhu; Hanna Schöpper; Elisabeth Engleder; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  J Negat Results Biomed       Date:  2016-05-11

7.  Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling.

Authors:  Jie Ren; Fangfang Jian; Hong Jiang; Yuhao Sun; Sijian Pan; Changwei Gu; Xiao Chen; Weiqing Wang; Guang Ning; Liuguan Bian; Qingfang Sun
Journal:  Int J Oncol       Date:  2018-04-03       Impact factor: 5.650

8.  Support Needs of Patients with Cushing's Disease and Cushing's Syndrome: Results of a Survey Conducted in Germany and the USA.

Authors:  Ilonka Kreitschmann-Andermahr; Sonja Siegel; Christa Gammel; Karen Campbell; Leslie Edwin; Agnieszka Grzywotz; Victoria Kuhna; Maria Koltowska-Häggström; Oliver Müller; Michael Buchfelder; Bernadette Kleist
Journal:  Int J Endocrinol       Date:  2018-10-09       Impact factor: 3.257

Review 9.  Systemic therapy of Cushing's syndrome.

Authors:  Niels Eckstein; Bodo Haas; Moritz David Sebastian Hass; Vladlena Pfeifer
Journal:  Orphanet J Rare Dis       Date:  2014-08-05       Impact factor: 4.123

10.  Past and present in abdominal surgery management for Cushing's syndrome.

Authors:  Ramon Vilallonga; Carles Zafon; José Manuel Fort; Jordi Mesa; Manel Armengol
Journal:  SAGE Open Med       Date:  2014-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.